1. Home
  2. GMED vs PATH Comparison

GMED vs PATH Comparison

Compare GMED & PATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GMED
  • PATH
  • Stock Information
  • Founded
  • GMED 2003
  • PATH 2005
  • Country
  • GMED United States
  • PATH United States
  • Employees
  • GMED N/A
  • PATH N/A
  • Industry
  • GMED Medical/Dental Instruments
  • PATH Computer Software: Prepackaged Software
  • Sector
  • GMED Health Care
  • PATH Technology
  • Exchange
  • GMED Nasdaq
  • PATH Nasdaq
  • Market Cap
  • GMED 7.9B
  • PATH 6.5B
  • IPO Year
  • GMED 2012
  • PATH 2021
  • Fundamental
  • Price
  • GMED $60.39
  • PATH $15.86
  • Analyst Decision
  • GMED Buy
  • PATH Hold
  • Analyst Count
  • GMED 14
  • PATH 17
  • Target Price
  • GMED $85.18
  • PATH $13.88
  • AVG Volume (30 Days)
  • GMED 1.2M
  • PATH 34.8M
  • Earning Date
  • GMED 11-06-2025
  • PATH 12-04-2025
  • Dividend Yield
  • GMED N/A
  • PATH N/A
  • EPS Growth
  • GMED 745.36
  • PATH N/A
  • EPS
  • GMED 2.57
  • PATH 0.04
  • Revenue
  • GMED $2,626,461,000.00
  • PATH $1,496,651,000.00
  • Revenue This Year
  • GMED $15.62
  • PATH $12.26
  • Revenue Next Year
  • GMED $8.00
  • PATH $8.85
  • P/E Ratio
  • GMED $23.47
  • PATH $417.59
  • Revenue Growth
  • GMED 17.43
  • PATH 8.25
  • 52 Week Low
  • GMED $51.79
  • PATH $9.38
  • 52 Week High
  • GMED $94.93
  • PATH $18.74
  • Technical
  • Relative Strength Index (RSI)
  • GMED 50.81
  • PATH 54.20
  • Support Level
  • GMED $61.50
  • PATH $15.41
  • Resistance Level
  • GMED $64.32
  • PATH $16.59
  • Average True Range (ATR)
  • GMED 1.45
  • PATH 0.98
  • MACD
  • GMED -0.03
  • PATH -0.17
  • Stochastic Oscillator
  • GMED 46.60
  • PATH 40.28

About GMED Globus Medical Inc.

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

About PATH UiPath Inc.

UiPath Inc offers an end-to-end cross-application enterprise automation platform principally with computer vision technology and user interface automations in its initial RPA offering, which remains the foundation of the platform. The platform leverages a range of automation technologies including robotic process automation, application programming interface, and artificial intelligence. UiPath's solution can automate a broad range of repetitive tasks across industries including claims processing, employee onboarding, invoice to cash, loan applications, and customer service.

Share on Social Networks: